Telemedicine collaboration model for managing heart failure patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to implement a telemedicine-based cross-sector collaboration model to manage patients with frequent admissions due to decompensated heart failure. It will involve helping patients utilize telemedicine tools, facilitating teleconferences between general practitioners and cardiologists, and guiding community health workers in assisting patients. The study will compare readmission rates and quality of life for patients before and after the implementation of this model. Participants will include patients admitted with acute decompensated heart failure and atrial fibrillation, along with their healthcare providers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients admitted with acute decompensated heart failure AND:

* with previous admission with decompensated heart failure in the three-month period prior to the current admission or
* who have two or more admissions in the 6 months prior to the current admission.

Exclusion Criteria:

* Patients who

  * have refused to share their data for health-quality projects
  * have already ongoing telemedicine management for heart failure

Where it's running

• Cardiology department Y, Bispebjerg-Frederiksberg Hospital
  Frederiksberg, Denmark Recruiting

Study contacts

• Study coordinator: Helena DOMINGUEZ, MD,PhD,Prof
• Email: mdom0002@regionh.dk
• Phone: 004522989343

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating different approaches to cardiac pacing in patients

  This study is testing different ways to place pacemakers in adults to see which methods work best and are safest for patients needing heart support.

  Recruiting at 31 sites University Hospital of Ferrara · Ferrara, FE and 30 other locations · NCT06324682

• AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

  This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

  Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

• Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities

  This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.

  Recruiting University Hospital Augsburg · Augsburg, Bavaria · NCT07857044

• Dual Energy ablation with SmartTouch SF catheter in persistent atrial fibrillation

  This study tests a pulsed field and radiofrequency ablation system to treat persistent atrial fibrillation in adults who have not responded well to prior medications.

  Recruiting at 4 sites Biosense Webster, Inc. · Beijing and 3 other locations · NCT07845682

• Identifying AF patients who may need more than standard ablation using Volta AF-Xplorer II

  This trial tests whether AI-identified dispersion areas during AF ablation can predict recurrence after a standard pulmonary vein isolation in patients with persistent AF.

  Recruiting Volta Medical · Avignon and 4 other locations · NCT07807423

• 4D intracardiac echocardiography to guide left atrial appendage occlusion procedures

  A new 4D ICE catheter is being tested alongside standard imaging to see if it can safely guide left atrial appendage occlusion procedures for adults with atrial fibrillation.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07806890

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.